Methyldopa in hypertension
- 31 January 1963
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 65 (1) , 139-140
- https://doi.org/10.1016/0002-8703(63)90228-x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- METHYLDOPA IN THE TREATMENT OF HYPERTENSIONThe Lancet, 1962
- METHYLDOPA IN HYPERTENSION CLINICAL AND PHARMACOLOGICAL STUDIESThe Lancet, 1962
- Effect of Alpha-Methyl DOPA in Severe and Malignant HypertensionPublished by American Medical Association (AMA) ,1962
- Clinical and Chemical Studies with α -Methyl-Dopa in Patients with HypertensionCirculation, 1962
- Monoamine Oxidase and Decarboxylase Inhibitors as Antihypertensive AgentsMedical Clinics of North America, 1961
- CLINICAL AND PHARMACOLOGICAL STUDIES WITH GUANETHIDINE IN THE TREATMENT OF HYPERTENSIONThe Lancet, 1960
- Decarboxylase Inhibition and Blood Pressure Reduction by α-Methyl-3,4-Dihydroxy-DL-phenylalanineScience, 1960
- Hemmung der Dopadecarboxylase durch ?-Methyldopa in vivoNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1958
- α-Methyl α-Amino Acids. II.1 Derivatives of DL-PhenylalanineJournal of the American Chemical Society, 1955
- Inhibition of dihydroxyphenylalanine decarboxylase by derivatives of phenylalanineArchives of Biochemistry and Biophysics, 1954